Commercially Available, FDA-approved Epigenetic Modifiers As Therapeutic Agents in Bacterial Infection

Publisher： Bentham Science Publishers

ISSN： 2212-7038

Source： Clinical Anti-Inflammatory & Anti-Allergy Drugs, Vol.2, Iss.1, 2015-04, pp. : 79-88

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Public misconceptions about FDA-approved drugs

By  

Reactions Weekly, Vol. 1, Iss. 1372, 2011-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

FDA-approved phenylephrine decongestant dose questioned

By  

Inpharma, Vol. 1, Iss. 1575, 2007-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Pharmacogenomic characterization of US FDA-approved cytotoxic drugs

By Peters Eric J   Motsinger-Reif Alison   Havener Tammy M   Everitt Lorraine   Hardison Nicholas E   Watson Venita G   Wagner Michael   Richards Kristy L   Province Mike A   McLeod Howard L  

Pharmacogenomics, Vol. 12, Iss. 10, 2011-10 ,pp. : 1407-1415

Future Medicine

Access to resources Recommend Favorite

Coverage Policy and Use Beyond the FDA-Approved Label

By McGivney William T.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 4, Iss. 2, 2006-02 ,pp. : 99-101

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

In Vitro Screening of an FDA-Approved Library Against ESKAPE Pathogens

By  

Current Pharmaceutical Design, Vol. 23, Iss. 14, 2017-05 ,pp. : 2147-2157

Bentham Science Publishers

Access to resources Recommend Favorite